How large is the erectile dysfunction market, and what is its growth trajectory?
The erectile dysfunction market size has grown strongly in recent years. It will grow from $2.46 billion in 2024 to $2.69 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to the rising incidence of cardiovascular diseases, increasing prevalence of diabetes, growing awareness of erectile dysfunction as a medical condition, an aging population leading to higher erectile dysfunction cases, and rising preference for personalized treatment options.
The erectile dysfunction market size is expected to see strong growth in the next few years. It will grow to $3.78 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to an increase in psychological factors, higher rates of obesity and metabolic disorders, growing demand for non-invasive erectile dysfunction treatments, an increase in patient consultations for sexual health, and increasing government initiatives to promote men’s health and lifestyle-related risk factors. Major trends in the forecast period include the expansion of e-pharmacies for erectile dysfunction drugs, advancements in penile implant technologies, technological advancements in erectile dysfunction diagnostics, innovative treatment methods targeting root causes of erectile dysfunction, and the introduction of effective phosphodiesterase type 5 inhibitors.
Get Your Free Sample of The Global Erectile Dysfunction Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21185&type=smp
What are the key forces behind the erectile dysfunction market’s growth in recent years?
The rising prevalence of lifestyle-related diseases is expected to drive the erectile dysfunction market. Lifestyle-related diseases are health conditions primarily caused by unhealthy habits, such as poor diet, lack of exercise, smoking, and excessive alcohol consumption. The increase in lifestyle-related diseases is due to rising sedentary behavior, poor dietary habits, stress, and unhealthy habits like smoking and excessive alcohol consumption. Erectile dysfunction (ED) serves as an early warning sign for lifestyle-related diseases, such as cardiovascular conditions and diabetes, highlighting the need for timely medical intervention and healthier lifestyle choices. For instance, in May 2022, according to the report published by the World Obesity Federation, a UK-based non-profit organization, by 2030, one billion people globally, including 1 in 5 women and 1 in 7 men, are projected to live with obesity, increasing to 4 billion people, or 51% of the global population, living either overweight or obese by 2035. Therefore, the rising prevalence of lifestyle-related diseases will propel growth of the erectile dysfunction market.
What are the major segments of the erectile dysfunction market?
The erectile dysfunction market covered in this report is segmented –
1) By Product: Drugs, Devices
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Channels
3) By End User: Hospitals And Clinics, Ambulatory Surgery Centers, Pharmacies, Other End Users
Subsegments:
1) By Drugs: Phosphodiesterase Type 5 (PDE5) Inhibitors, Hormone Therapy, Injectable Medications, Topical Medications
2) By Devices: Vacuum Erection Devices (VEDs), Penile Implants, Shockwave Therapy Devices
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/erectile-dysfunction-global-market-report
Which companies dominate the erectile dysfunction market?
Major companies operating in the erectile dysfunction market are Pfizer Inc., Bayer AG, Dong-A Socio Holdings Co. Ltd., Sanofi S.A., GlaxoSmithKline plc, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Limited, Boston Scientific Corporation, Sandoz International GmbH, Sun Pharmaceutical Industries Limited, Coloplast Corporation, Dr. Reddy’s Laboratories Limited, Cipla Limited, Ferring Pharmaceuticals A/S, Endo International plc, Zydus Lifesciences Limited, Lupin Limited, Hims & Hers Health Inc., Cadila Pharmaceuticals Limited, VIVUS Inc., Rigicon Inc., Petros Pharmaceuticals Inc., Futura Medical plc, Apricus Biosciences Inc., Pos-T-Vac Medical Inc., Initiator Pharma A/S
What major trends will shape the erectile dysfunction market during the forecast period?
Major companies operating in the erectile dysfunction market are focusing on innovative products, such as over-the-counter (OTC) gel, to provide more accessible and convenient treatment options for individuals experiencing erectile dysfunction, thereby expanding their market reach and addressing unmet patient needs. An over-the-counter (OTC) gel is a topical medication available without a prescription, used for treating various conditions directly applied to the skin. For instance, in September 2024, Haleon plc, a UK-based consumer healthcare company, launched Eroxon, the first FDA-cleared over-the-counter gel for erectile dysfunction (ED). This innovative product offers a non-invasive, fast-acting solution for ED, designed to provide enhanced accessibility and convenience for patients. Its ease of use, offering a topical application that eliminates the need for oral medications, reducing potential systemic side effects.
What are the key regional dynamics of the erectile dysfunction market, and which region leads in market share?
North America was the largest region in the erectile dysfunction market in 2024. The regions covered in the erectile dysfunction market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Erectile Dysfunction Market Report 2025 Offer?
The erectile dysfunction market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Erectile dysfunction (ED) refers to the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It is a common condition that can result from various physical, psychological, or lifestyle factors, affecting men’s overall well-being and quality of life.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21185
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
